As Aurora-A interacts with cyclin B1, inhibiting cyclin B1 degradation [73], targeting the Aurora-A–cyclin B1 axis suggests promising new approaches for obesity-induced breast cancer prevention and treatment resistance [72]. The gene discussed is CCNB1; the disease is breast carcinoma.